Il mercato controllato dai pazienti è stato valutato a 2.969,47 milioni di dollari nel 2019 e si prevede che raggiungerà 7.505,70 milioni di dollari entro il 2027; si prevede che crescerà a un CAGR del 12,4% dal 2020 al 2027.
Gli iniettori controllati dal paziente sono la recente invenzione nella somministrazione di iniezioni. Ci sono bisogni altamente insoddisfatti di persone/operatori sanitari o pazienti’ che richiedono iniettori controllati dal paziente, poiché ha maggiore facilità e comodità rispetto a qualsiasi altro autoiniettore. Questi sono sviluppati ergonomicamente e il design degli iniettori controllati dal paziente può aiutare a ottimizzare la cura di sé, rendendo più semplice per i pazienti gestire il sistema e somministrare i dosaggi con una sola pressione. Si prevede che il mercato degli iniettori controllati dal paziente assisterà a una crescita significativa dovuta alla crescente prevalenza di malattie infettive e alla crescente enfasi sulla migliore compliance del paziente. Tuttavia, è probabile che la scarsa adozione degli iniettori nei paesi emergenti scoraggi la crescita del mercato durante il periodo di previsione.
Regioni redditizie per il mercato degli iniettori controllati dal paziente
Approfondimenti di mercato
Crescente prevalenza di malattie croniche
Gli iniettori controllati dal paziente sono sistemi di somministrazione sottocutanea di farmaci che aderiscono al corpo e somministrano volumi maggiori (più (più di 2 ml) di un farmaco per un periodo prolungato. Con l'uso di iniettori controllati dal paziente, è possibile evitare errori di dosaggio, rischi di contaminazione microbica e lesioni da puntura d'ago causati durante la somministrazione parenterale di farmaci mediante iniezioni. Negli ultimi anni l’industria farmaceutica ha assistito all’introduzione di numerosi interventi innovativi per il trattamento di diverse malattie croniche. Tuttavia, la maggior parte delle opzioni terapeutiche disponibili richiedono la somministrazione di farmaci per via parenterale, somministrazioni frequenti e ripetute visite ospedaliere. Pertanto, gli iniettori controllati dal paziente sono preferiti per il trattamento di malattie croniche in cui è necessario un trattamento a lungo termine. Le malattie croniche, come le malattie del sangue, le malattie autoimmuni e vari tipi di cancro, sono le principali cause di morte e disabilità in tutto il mondo. Secondo i Centri per il controllo e la prevenzione delle malattie, nel 2019, quasi 6 persone su 10 soffrono di almeno una malattia cronica negli Stati Uniti.
Malattie cardiovascolari (CVD) sono una causa significativa di mortalità a livello globale a causa dello stile di vita frenetico. Secondo l’Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari sono la prima causa di morte a livello globale, con una stima di 17,9 milioni di vittime ogni anno. Molti farmaci biologici sono disponibili in commercio per il trattamento, ma i metodi convenzionali di somministrazione dei farmaci non sono in grado di fornire un dosaggio accurato. Ciò aumenta l’uso di sistemi di somministrazione di farmaci tramite iniezioni controllate dal paziente che forniscono una somministrazione mirata di farmaci e una permanenza prolungata del farmaco nelle aree interessate del sistema cardiovascolare. Pertanto, è probabile che l'adozione di iniettori controllati dal paziente aumenti, stimolando così la crescita del mercato.
Approfondimenti basati sul prodotto
In base al prodotto, il mercato degli iniettori controllati dal paziente è segmentato in iniettore elettronico indossabile, iniettore meccanico indossabile e pompe per infusione. Nel 2019, il segmento degli iniettori elettronici indossabili deteneva la quota maggiore del mercato; mentre è probabile che il segmento degli iniettori meccanici indossabili testimonierà la crescita più rapida durante il periodo di previsione.
Mercato globale degli iniettori controllati dal paziente, per prodotto - 2019 e 2027
Approfondimenti basati sull'applicazione
In base all'applicazione, il mercato degli iniettori controllati dal paziente è segmentato in trattamento del cancro, trattamento autoimmune, trattamento delle malattie del sangue e altri. Il segmento del trattamento del cancro ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà la crescita più rapida durante il periodo di previsione.
Approfondimenti basati sul canale di distribuzione
In base al canale di distribuzione, il mercato degli iniettori controllati dal paziente è segmentato in farmacie ospedaliere, farmacie al dettaglio e vendita per corrispondenza farmacie. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà la crescita più rapida durante il periodo di previsione.
La domanda di iniettori controllati dal paziente è aumentata durante la pandemia. Fattori come l’aumento della popolazione di pazienti, la carenza di risorse sanitarie e la facilità di aumentare l’adozione di iniettori hanno avuto in una certa misura un impatto positivo sul mercato. Tuttavia, l’attuazione di politiche di distanziamento fisico e la chiusura totale delle imprese al fine di prevenire l’infezione virale hanno interrotto le operazioni della catena di approvvigionamento, il che, a sua volta, ha causato un impatto negativo sulla crescita del mercato.
Approfondimenti strategici
La strategia di lancio e espansione dei prodotti viene comunemente adottata dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Questa strategia viene comunemente adottata dagli operatori del mercato al fine di espandere il proprio portafoglio di prodotti.
Gli operatori del mercato che operano nel mercato degli iniettori controllati dal paziente hanno adottato la strategia dell'innovazione del prodotto per soddisfare la mutevole domanda dei clienti in tutto il mondo, il che consente anche ai giocatori di mantenere il proprio marchio a livello globale.
Mercato degli iniettori controllati dal paziente: Per prodotto
- Iniettore indossabile elettronico
- Iniettore indossabile meccanico
- Pompe per infusione
Paziente Mercato degli iniettori controllati: Per applicazione
- Trattamento del cancro
- Trattamento autoimmune
- Trattamento delle malattie del sangue
- Altro
Mercato degli iniettori controllati dal paziente - Per canale di distribuzione
- Farmacie ospedaliere
- Farmacie al dettaglio
- Farmacie per corrispondenza
Paziente Mercato degli iniettori controllati: Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- Sud e; America Centrale (SCAM)
- Brasile
- Argentina
- Resto di SCAM
  ;
Profili aziendali
- Gerresheimer AG
- F. Hoffmann-La Roche Ltd.
- Johnson and Johnson Services, Inc.
- Ypsomed AG
- Westbourne Medical Limited
- Abilita iniezioni
- scPharmaceuticals Inc.
- United Therapeutics Corporation
- BD
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The patient-controlled injectors are the newest invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients requiring the patient-controlled injectors as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press.
The growth of the market is attributed to the increasing prevalence of chronic diseases and growing patient compliance.
Gerresheimer AG, F. HOFFMANN-LA ROCHE LTD., Johnson and Johnson Services, Inc., Ypsomed AG, Westbourne Medical Limited, Enable Injections, scPharmaceuticals Inc., United Therapeutics Corporation and BD are some of the major players in the patient controlled injectors market.
The List of Companies - Patient Controlled Injectors Market
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Ypsomed AG
- Westbourne Medical Limited
- Enable Injections
- scPharmaceuticals Inc.
- United Therapeutics Corporation
- BD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)